Nikolaus Benjamin Wagner

9PUBLICATIONS
14CO-AUTHORS
Tumour immunologyCancer diagnosisMedical infection agents (incl. prions)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 20, 2026
Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma.

Nicola Herold, Jonas Bochem, Johanna Leyens

|May 28, 2022
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.

Lisa Kostner, Sara Elisa Cerminara, Gustavo Santo Pedro Pamplona

|Aug 07, 2021
Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas.

Maximilian Gassenmaier, Matthias Hahn, Gisela Metzler

|May 14, 2021
Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.

Nikolaus B Wagner, Max M Lenders, Kathrin Kühl

|Feb 08, 2021
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors.

Maximilian Gassenmaier, Max M Lenders, Andrea Forschner

|Oct 28, 2020
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors.

Johanna Winter, Max M Lenders, Maximilian Gassenmaier

Pageof 2

Frequent Collaborators

2 joint publications

Patrick Terheyden

2 joint publications

Kilian Wistuba-Hamprecht

1 joint publications

Andrea Forschner

1 joint publications

Christoffer Gebhardt